2BB score and signals
Crescent Biopharma, Inc.’s current 2BB score is 57 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 79 | High |
| Momentum | 72 | Improving |
| Financial strength | 23 | Weak |
| Quality | 64 | Strong |
| Risk | 58 | Moderate |
Company facts
| Headquarters | Waltham, Massachusetts, United States |
| Founded | 2024 |
| Employees | 69 |
| 52-week range | $8.72 – $27.41 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-24 | — | -0.7583 | — | $318,750.00 |
| 2026-11-04 | — | -0.7302 | — | $318,750.00 |
| 2026-04-29 | -0.7 | -0.9655 | $1.04M | $364,282.00 |
| 2026-02-26 | -0.54 | -2.5666 | $10.84M | $3.40M |
Related companies
